← FDA DRUG APPROVALS

FDA ANDA · ANDA207956

SODIUM CHLORIDE

Sponsor: LABORATORIOS GRIFOLS

APPLICATION
ANDA207956
TYPE
ANDA
ORIGINAL APPROVAL
2017-05-25
LATEST ACTION
2026-03-11
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERPrescription
SODIUM CHLORIDE 900MG/100ML · INJECTABLE · INJECTION

Approval history

2026-03-11Labeling · Supplement 7 · standardAP
2020-06-09Labeling · Supplement 4 · standardAP
2017-05-25UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →